Property:Age groups specification
This is a property of type Text.
L
Lyckholm et al. (2012): A randomized, placebo controlled trial of oral zinc for chemotherapy-related taste and smell disorders +
Mean: 53 +
M
Mahmoodnia et al. (2017): Ameliorative effect of lycopene effect on cisplatin-induced nephropathy in patients +
Age in years, mean (SD), range: 57.5 (12.65), 18-82 +
Mansouri et al. (2016): The Effect of Aloe Vera Solution on Chemotherapy-Induced Stomatitis in Clients with Lymphoma and Leukemia: A Randomized Controlled Clinical Trial +
Mean age (SD) per arm:
Aloe arm: 46.25(18.17) years
Placebo arm: 47.78(18.28) years +
Mansourian et al. (2015): The effect of "curcuma Longa" topical gel on radiation -induced oral mucositis in patients with head and neck cancer +
Mean (SD): 51.34 (12.08) years +
Mantovani et al. (2010): Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia +
Mean(SD): 63(12) years +
Margalit et al. (2012): Beta-carotene Antioxidant Use During Radiation Therapy and Prostate Cancer Outcome in the Physicians’ Health Study +
Age at diagnosis (years) in median (IQR)
- intervention group: 73 (68, 76)
- placebo group: 73 (69, 76)
Age at treatment (years) in median (IQR)
- intervention group: 73 (68, 76)
- placebo group: 73 (69, 76) +
Martin et al. (2002): Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial +
Mean age per arm:
Enzyme arm: 53.8 years
Placebo arm: 57.3 years +
Marucci et al. (2017): Double-blind randomized phase III study comparing a mixture of natural agents versus placebo in the prevention of acute mucositis during chemoradiotherapy for head and neck cancer +
Median age (range) per arm:
Aloe arm = 55 (30-74)
Placebo arm = 59 (26-76) +
Marx et al. (2017): The Effect of a Standardized Ginger Extract on Chemotherapy-Induced Nausea-Related Quality of Life in Patients Undergoing Moderately or Highly Emetogenic Chemotherapy: A Double Blind, Randomized, Placebo Controlled Trial +
Mean (SD) intervention vs. placebo: 57 (14) vs. 59 (11) years +
Mayne et al. (2001): Randomized Trial of Supplemental beta-Carotene to Prevent Second Head and Neck Cancer +
Per group mean (SD)
- intervention: 67.8 (9.8)
- placebo: 67.9 (9.3) +
Mazdak et al. (2012): Vitamin E reduces superficial bladder cancer recurrence: A randomized controlled Trial +
Mean (SD) = 59.8 (12.5) years +
Meyskens et al. (1995): Effects of vitamin A on survival in patients with chronic myelogenous leukemia: a SWOG randomized trial +
Median per group:
- intervention group: 51
- control group: 46 +
Minchom et al. (2014): An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of (...) +
Age at diagnosis (years) per arm, median (IQR):
- intervention: 61 (12)
- control: 60 (14) +
Mix et al. (2015): Randomized phase II trial of selenomethionine as a modulator of efficacy and toxicity of chemoradiation in squamous cell carcinoma of the head and neck +
Median: 57 years +
Mondal et al. (2014): Comparative study among glutamine, acetyl-L-carnitine, vitamin-E and methylcobalamine for treatment of paclitaxel-induced peripheral neuropathy +
Mean (SD) = 54.2 (1.1) years +
Montazeri et al. (2013): Effect of Herbal Therapy to Intensity Chemotherapy-Induced Nausea and Vomiting in Cancer Patients +
Mean(SD): 50.3 (13.1) years +
Montazeri et al. (2013): Iranian Red Crescent Medical JournalEffect of Herbal Therapy to Intensity Chemotherapy-Induced Nausea and Vomiting in Cancer Patients. +
? +
Moslemi et al. (2014): Oral zinc sulphate and prevention of radiation-induced oropharyngealmucositis in patients with head and neck cancers: A double blind, randomized controlled clinical trial +
Intervention arm: mean (SD): 49.5 (17.47), Range: 18–78
placebo arm: mean (SD): 52.82 (14.03), Range: 22 –71 +
Muecke et al. (2010): Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology +
Mean (SD), range: 64.3 (10.1), 31–80 years +